Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality
- PMID: 20648003
- DOI: 10.1038/ajg.2010.287
Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality
Abstract
Objectives: Although drug-induced liver injury (DILI) is rare, it may result in significant morbidity or death. The causes and outcome vary according to regions, with acetaminophen and complementary medicines common in the West and the Far East, respectively. This study evaluates the causes, outcomes, predictors, and models for 90-day mortality from DILI from India.
Methods: Consecutive patients with DILI from 1997 to 2008 based on International Consensus Criteria from a medical college hospital setting were studied.
Results: Of the 313 patients, 58% were males. Leading causes were a combination of four anti-tuberculous drugs (ATDs) (58%), anti-epileptics (11%), olanzapine (5.4%), and dapsone (5.4%). The overall 90-day mortality of 17.3% was significantly higher for ATD hepatitis (21.5%) vs. those without (11.4%) (P=0.02). The highest mortality was for leflunomide (75%). Seventy-eight percent of patients received more than one drug. Fulminant hepatic failure developed more commonly in females than in males (23% vs. 17%). Of the 66% of cases with jaundice and/or icterus, mortality was 26%. Multivariable models for mortality using a combination of encephalopathy, ascites, and bilirubin, or a combination of albumin, prothrombin time, and white blood cell count yielded a C-statistic of at least 0.86 by recursive partitioning and 0.92 by logistic regression. Model for end stage liver disease (MELD) scores of 38 and 46 yield probabilities of death of 0.90 (confidence interval (CI): 0.71-0.97) and 0.99 (CI: 0.90-1.00), respectively.
Conclusions: DILI results in significant overall mortality (17.3%). ATDs, anti-convulsants, sulphonamides, and olanzapine are the leading causes of DILI. Although common in males, more females developed fulminant hepatic failure. High-MELD score or a combination of ascites, encephalopathy, high bilirubin, prothrombin time, and leukocyte count are predictive of mortality.
Similar articles
-
Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients.Liver Int. 2018 Jul;38(7):1322-1329. doi: 10.1111/liv.13662. Epub 2017 Dec 22. Liver Int. 2018. PMID: 29222960
-
Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.J Gastroenterol Hepatol. 2013 Jan;28(1):161-7. doi: 10.1111/j.1440-1746.2012.07279.x. J Gastroenterol Hepatol. 2013. PMID: 23020522
-
Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.Ann Hepatol. 2017 May-Jun;16(3):442-450. doi: 10.5604/16652681.1235488. Ann Hepatol. 2017. PMID: 28425415
-
Antituberculous drug-induced liver injury: current perspective.Trop Gastroenterol. 2011 Jul-Sep;32(3):167-74. Trop Gastroenterol. 2011. PMID: 22332331 Review.
-
The natural history of drug-induced liver injury.Semin Liver Dis. 2009 Nov;29(4):357-63. doi: 10.1055/s-0029-1240004. Epub 2009 Oct 13. Semin Liver Dis. 2009. PMID: 19826969 Review.
Cited by
-
An Update on Drug-induced Liver Injury.J Clin Exp Hepatol. 2012 Sep;2(3):247-59. doi: 10.1016/j.jceh.2012.05.002. Epub 2012 Sep 21. J Clin Exp Hepatol. 2012. PMID: 25755441 Free PMC article. Review.
-
Expression of type I collagen in response to Isoniazid exposure is indirect and is facilitated by collateral induction of cytochrome P450 2E1: An in-vitro study.PLoS One. 2020 Jul 31;15(7):e0236992. doi: 10.1371/journal.pone.0236992. eCollection 2020. PLoS One. 2020. PMID: 32735603 Free PMC article.
-
Drug-Induced Liver Injury Unique to India.Clin Liver Dis (Hoboken). 2021 Oct 15;18(3):108-110. doi: 10.1002/cld.1120. eCollection 2021 Sep. Clin Liver Dis (Hoboken). 2021. PMID: 34691395 Free PMC article. Review. No abstract available.
-
A comprehensive update in herbal and dietary supplement-induced liver injury.Clin Liver Dis (Hoboken). 2024 Jun 21;23(1):e0185. doi: 10.1097/CLD.0000000000000185. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38912001 Free PMC article. No abstract available.
-
Clinical perspective: statins and the liver--harmful or helpful?Dig Dis Sci. 2012 Jul;57(7):1754-63. doi: 10.1007/s10620-012-2207-3. Epub 2012 May 12. Dig Dis Sci. 2012. PMID: 22581301 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials